NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug hope: can sotagliflozin help HCM patients breathe easier?
Symptom relief Recruiting nowThis study tests a drug called sotagliflozin in 500 adults with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens, making it harder to pump blood. The goal is to see if the drug improves symptoms like shortness of breath and fatigue, and helps people …
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated May 26, 2026 09:39 UTC
-
New drug aims to help hearts work better in stiff heart condition
Symptom relief Recruiting nowThis study tests an experimental drug called ninerafaxstat in 165 adults with a type of thickened heart muscle that causes symptoms like shortness of breath and chest pain. The drug is added to standard care and compared to a placebo to see if it improves daily function and quali…
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC